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Background:  Large registries have shown a higher mortality in patients with unsuccessful chronic total occlusion (CTO)-PCI for left anterior 
descending artery (LAD) as compared to nonLAD-CTO. Furthermore, patients with incomplete coronary revascularization due to non attempetd or 
failed CTO-PCI had a poor prognosis as compared to patients with a complete revascularization. No data exist about the prognostic impact of drug 
eluting stent (DES) supported successful PCI for LAD-CTO in patients with a complete coronary revascularization achieved by PCI.
Methods:  From the prospective Florence CTO-PCI registry, since 2004 to 2009, 530 patients underwent a successful PCI for CTO (>3 months) 
with a complete coronary revascularization within one month. The prognostic impact of LAD-CTO on cardiac mortality was assessed by Kaplan-Meier 
estimation and by forward stepwise Cox regression multivariate analysis.
Results:  A successful CTO-PCI with a complete coronary revascularization was achieved in 155 patients with LAD-CTO and in 375 patients with 
nonLAD-CTO.
Baseline characteristics of patients with LAD-CTO vs nonLAD-CTO were similar: mean age 68±11 vs 67±11 yrs, male 83% vs 86 %, diabetes 24% vs 
22%, previous myocardial infarction 52% vs 46%, acute coronary syndrome at admission 39% vs 32%, 3-vessel coronary disease 44% vs 48%, left 
ventricular ejection fraction (EF) 43%±13 vs 45%±12. All patients received DES (median stent lenght in LAD-CTO 36 mm vs 46 mm in non-LAD-CTO; 
p=.010) A multivessel PCI was performed in 70% of both groups.
The 6-9 months angiographic patency rate (FU rate: 81%) of CTOs was 91.6% (96% in LAD-CTO vs 90% in nonLAD-CTO; p=.045). The cardiac survival 
rate (median 1.2 yrs) was higher in the nonLAD-CTO group as compared to LAD-CTO group (97% ± 1.7% vs 89% ± 3.5%; p<.001). At multivariate 
analysis the independent predictors related to cardiac mortality were LAD-CTO (HR 3.8; p=.009), age (HR 1.1; p=.004) and EF (HR 0.9; p<.001).
Conclusions:  The successful treatment of nonLAD-CTO associated with a complete revascularization link with a very high survival rate. LAD-CTO is 
a predictor of cardiac mortality despite the completeness of coronary revascularization and a high sustained patency rate. 
